- Home
- WFF vs MBRX Comparison
WFF vs MBRX Comparison
Compare WFF & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFF
- MBRX
- Stock Information
- Founded
- WFF 1984
- MBRX 2015
- Country
- WFF Malaysia
- MBRX United States
- Employees
- WFF N/A
- MBRX N/A
- Industry
- WFF Miscellaneous manufacturing industries
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- WFF Consumer Discretionary
- MBRX Health Care
- Exchange
- WFF Nasdaq
- MBRX Nasdaq
- Market Cap
- WFF 22.4M
- MBRX 24.3M
- IPO Year
- WFF 2025
- MBRX 2016
- Fundamental
- Price
- WFF $0.97
- MBRX $0.51
- Analyst Decision
- WFF
- MBRX Strong Buy
- Analyst Count
- WFF 0
- MBRX 4
- Target Price
- WFF N/A
- MBRX $5.00
- AVG Volume (30 Days)
- WFF 925.8K
- MBRX 2.7M
- Earning Date
- WFF 11-24-2025
- MBRX 11-07-2025
- Dividend Yield
- WFF N/A
- MBRX N/A
- EPS Growth
- WFF N/A
- MBRX N/A
- EPS
- WFF 0.00
- MBRX N/A
- Revenue
- WFF $4,572,290.00
- MBRX N/A
- Revenue This Year
- WFF N/A
- MBRX N/A
- Revenue Next Year
- WFF N/A
- MBRX N/A
- P/E Ratio
- WFF $197.63
- MBRX N/A
- Revenue Growth
- WFF N/A
- MBRX N/A
- 52 Week Low
- WFF $0.81
- MBRX $0.25
- 52 Week High
- WFF $29.26
- MBRX $3.65
- Technical
- Relative Strength Index (RSI)
- WFF N/A
- MBRX 53.09
- Support Level
- WFF N/A
- MBRX $0.42
- Resistance Level
- WFF N/A
- MBRX $0.50
- Average True Range (ATR)
- WFF 0.00
- MBRX 0.04
- MACD
- WFF 0.00
- MBRX 0.01
- Stochastic Oscillator
- WFF 0.00
- MBRX 57.02
About WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.